EIB backs Italian medtech Tensive with up to €20 million to advance breast reconstruction innovation
The European Investment Bank (EIB) is providing up to €20 million in convertible venture debt financing to Tensive, an Italian clinical stage medical technology company developing advanced biomaterials for regenerative medicine applications. The financing will support the company’s research and development activities and capital expenditure to advance bioresorbable implants for reconstructive surgery and tissue marking following lumpectomy in breast cancer patients.
Read releases like this the second they cross the wire.
1,100+ feeds from 80+ newswires in one live cockpit — saved searches, instant alerts, AI summaries. 7-day free trial, no card required.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live on PPN World.
PPN Source →